New Eli Lilly Drug Boosts Weight Loss

Many people struggle with weight loss. Now, Eli Lilly has good news. The company tested a new drug combination. It mixes two powerful drugs: tirzepatide and eloralintide.

Early tests showed big results. Patients lost much more weight with the combination than with tirzepatide alone. Eli Lilly plans to start bigger tests soon. These tests, called Phase 3 trials, will begin later this year.

If these trials go well, the new combination could become a strong tool for doctors. It could help millions achieve their health goals. This is a bright spot for people seeking effective weight loss solutions.

Source: CNBC